These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1191 related articles for article (PubMed ID: 18760135)
21. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold M; Abraham WT; Daubert JC; Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890 [TBL] [Abstract][Full Text] [Related]
22. Expanding cardiac resynchronization for systolic heart failure to patients with mechanical dyssynchrony and atrial fibrillation. Ghanbari H; Hassunizadeh B; Machado C Rev Cardiovasc Med; 2005; 6(3):140-51. PubMed ID: 16195687 [TBL] [Abstract][Full Text] [Related]
23. Influence of diabetes on cardiac resynchronization therapy with or without defibrillator in patients with advanced heart failure. Ghali JK; Boehmer J; Feldman AM; Saxon LA; Demarco T; Carson P; Yong P; Galle EG; Leigh J; Ecklund FL; Bristow MR J Card Fail; 2007 Nov; 13(9):769-73. PubMed ID: 17996827 [TBL] [Abstract][Full Text] [Related]
24. Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure. Herweg B; Ilercil A; Cutro R; Dewhurst R; Krishnan S; Weston M; Barold SS Am J Cardiol; 2007 Jul; 100(1):90-3. PubMed ID: 17599447 [TBL] [Abstract][Full Text] [Related]
25. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. Leclercq C; Gadler F; Kranig W; Ellery S; Gras D; Lazarus A; Clémenty J; Boulogne E; Daubert JC; J Am Coll Cardiol; 2008 Apr; 51(15):1455-62. PubMed ID: 18402900 [TBL] [Abstract][Full Text] [Related]
26. The use of atrial overdrive and ventricular rate stabilization pacing algorithms for the prevention and treatment of paroxysmal atrial fibrillation: the Pacemaker Atrial Fibrillation Suppression (PAFS) study. Sulke N; Silberbauer J; Boodhoo L; Freemantle N; Kamalvand K; O'Nunain S; Hildick-Smith D; Lloyd GW; Patel NR; Paul V Europace; 2007 Sep; 9(9):790-7. PubMed ID: 17562750 [TBL] [Abstract][Full Text] [Related]
27. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study. De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768 [TBL] [Abstract][Full Text] [Related]
28. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry). Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A; Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388 [TBL] [Abstract][Full Text] [Related]
29. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. Hsieh MH; Tai CT; Lee SH; Tsao HM; Lin YK; Huang JL; Chan P; Chen YJ; Kuo JY; Tuan TC; Hsu TL; Kong CW; Chang SL; Chen SA J Cardiovasc Electrophysiol; 2005 May; 16(5):457-61. PubMed ID: 15877612 [TBL] [Abstract][Full Text] [Related]
30. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial. Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084 [TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy. The Resynchronization for the HemodYnamic Treatment for Heart Failure Management II implantable cardioverter defibrillator (RHYTHM II ICD) study. Boriani G; Müller CP; Seidl KH; Grove R; Vogt J; Danschel W; Schuchert A; Djiane P; Biffi M; Becker T; Bailleul C; Trappe HJ; Am Heart J; 2006 May; 151(5):1050-8. PubMed ID: 16644335 [TBL] [Abstract][Full Text] [Related]
32. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS? Gasparini M; Regoli F; Galimberti P; Ceriotti C; Bonadies M; Mangiavacchi M; Andreuzzi B; Bragato R; Pini D; Klersy C; Gronda E Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S34-9. PubMed ID: 17302713 [TBL] [Abstract][Full Text] [Related]
33. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Tan ES; Rienstra M; Wiesfeld AC; Schoonderwoerd BA; Hobbel HH; Van Gelder IC Europace; 2008 Apr; 10(4):412-8. PubMed ID: 18272509 [TBL] [Abstract][Full Text] [Related]
34. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Gasparini M; Bocchiardo M; Lunati M; Ravazzi PA; Santini M; Zardini M; Signorelli S; Passardi M; Klersy C; Am Heart J; 2006 Jul; 152(1):155.e1-7. PubMed ID: 16824846 [TBL] [Abstract][Full Text] [Related]
35. Contributions of permanent cardiac pacing in the treatment of atrial fibrillation. Schuchert A Europace; 2004 Sep; 5 Suppl 1():S36-41. PubMed ID: 15450278 [TBL] [Abstract][Full Text] [Related]
36. Safety and feasibility of a novel rate-smoothed ventricular pacing algorithm for atrial fibrillation. Simpson CS; Yee R; Lee JK; Braney M; Klein GJ; Krahn AD; Skanes AC Am Heart J; 2001 Aug; 142(2):294-300. PubMed ID: 11479469 [TBL] [Abstract][Full Text] [Related]
37. No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation. de Voogt W; van Hemel N; de Vusser P; Mairesse GH; van Mechelen R; Koistinen J; van den Bos A; Roose I; Voitk J; Yli-Mäyry S; Stockman D; El Allaf D; Tse HF; Lau CP Europace; 2007 Sep; 9(9):798-804. PubMed ID: 17670782 [TBL] [Abstract][Full Text] [Related]
38. [Cardiac resynchronization therapy by biventricular pacing. How many patients with left ventricular dysfunction are eligible?]. Yang A; Wolpert C; Schimpf R; Schulz T; Krause U; Jung W; Herwig S; Jeong KM; Omran H; Lewalter T; Lüderitz B Dtsch Med Wochenschr; 2002 Oct; 127(43):2259-63. PubMed ID: 12397540 [TBL] [Abstract][Full Text] [Related]
39. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials. Pires LA; Abraham WT; Young JB; Johnson KM; Am Heart J; 2006 Apr; 151(4):837-43. PubMed ID: 16569543 [TBL] [Abstract][Full Text] [Related]
40. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study. Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]